Baker Bros. Advisors’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,406,037
Closed -$8.87M – 131
2021
Q2
$8.87M Hold
1,406,037
– – 0.04% 80
2021
Q1
$8.69M Hold
1,406,037
– – 0.04% 80
2020
Q4
$9.7M Hold
1,406,037
– – 0.04% 75
2020
Q3
$7.93M Sell
1,406,037
-229,464
-14% -$1.09M 0.03% 71
2020
Q2
$8.34M Hold
1,635,501
– – 0.04% 67
2020
Q1
$5.63M Buy
1,635,501
+1,493,751
+1,054% +$8.73M 0.03% 64
2019
Q4
$1.22M Buy
+141,750
New +$506K 0.01% 91
2016
Q4
– Sell
-35,649
Closed -$1.64M – 137
2016
Q3
$1.64M Hold
35,649
– – 0.01% 101
2016
Q2
$1.82M Hold
35,649
– – 0.02% 100
2016
Q1
$1.51M Hold
35,649
– – 0.02% 107
2015
Q4
$2.8M Hold
35,649
– – 0.02% 98
2015
Q3
$1.44M Hold
35,649
– – 0.01% 112
2015
Q2
$1.86M Hold
35,649
– – 0.02% 103
2015
Q1
$1.66M Sell
35,649
-1,127
-3% -$58.5K 0.01% 111
2014
Q4
$1.65M Hold
36,776
– – 0.02% 103
2014
Q3
$1.43M Hold
36,776
– – 0.02% 93
2014
Q2
$1.56M Hold
36,776
– – 0.02% 94
2014
Q1
$1.31M Sell
36,776
-66,264
-64% -$2.24M 0.02% 94
2013
Q4
$3.33M Buy
+103,040
New +$3.06M 0.05% 72

Other funds holding ISEE

Baker Bros. Advisors's ISEE Position: Q3 2021 in Review

Baker Bros. Advisors sold out of IVERIC bio (ISEE) in Q3 2021, closing a stake of 1,406,037 shares — an estimated $8.87M sold.

Baker Bros. Advisors first reported a position in ISEE in Q4 2013 and held it in 19 quarters. The position peaked at $9.7M in Q4 2020. 149 funds tracked by Wall St. Rank hold ISEE as of Q3 2021.

  • Baker Bros. Advisors reported no remaining IVERIC bio position as of Q3 2021 after selling out during the quarter.
  • Baker Bros. Advisors sold 1,406,037 IVERIC bio shares in Q3 2021, an estimated $8.87M.
  • Baker Bros. Advisors first reported a position in IVERIC bio in Q4 2013 and held it in 19 quarters.
  • Baker Bros. Advisors's IVERIC bio position peaked at $9.7M in Q4 2020.
  • 149 funds tracked by Wall St. Rank held IVERIC bio as of Q3 2021.

Based on Baker Bros. Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.